PDF Archive search engine
Last database update: 15 May at 07:37 - Around 76000 files indexed.

Show results per page

Results for «metastases»:

Total: 24 results - 0.056 seconds

JDIT-2015-0508-017 100% Letter A Reirradiation of spinal metastases using an add-on double-focus micro multileaf collimator and a three partial-arc conformal avoidance technique with optimized beam weights:


JDIT-2016-0906-024 84%

55-58 However, since the sensitivity of 11C-choline positron emission tomography/computed tomography (PET/CT) is higher in comparison to bone scintigraphy and also because of the capability of PET/CT to investigate local recurrence and lymph node metastases, the patient underwent subsequent 11C-choline PET/CT to further exclude macroscopic disease.


ER1107 82%

Dr Martin Holcmann 09:30 - 10.30 Invasive vs non-invasive treatment for liver metastases.


ER1143 82%

Metastatic disease 11.15am Synchronous liver metastases:


JDIT-2015-0428-016 72%

HCC and liver metastases represent different tumour types, with more peripheral vascularization in HCC and a higher proportion of smaller lesions in metastases [5].


JDIT-2016-0116-020 68%

Articles published in 2015 have covered the topics on the application of nano-particles towards imaging and therapy, quantification of PET/CT images, the role of [18F]FDG positron emission tomography (PET) imaging for glucose transporter GLUT1, bifunctional metal - nitroimidazole complexes for hypoxia theranosis in cancer, 3-D image-based dosimetry using 90Y microsphere therapy, reirradiation of spinal metastases using micro multileaf collimator, nano-aptamer for breast cancer imaging and gallium-68 radiotracers for Alzheimer’s plaque imaging.


CV Shiban 29-03-2017 63%

Intraoperative neuromonitoring for function-guided resection differs for supratentorial motor eloquent gliomas and metastases.


JDIT-2014-1030-006 61%

Generally are well differentiated tumors but often present metastases at diagnosis.




melanoma 59%

“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness.


ESMO-Preceptorship-on-Lung-Cancer-Manchester-2020-Programme.ocr 56%

Solheim , NO Catherine McBain, UK 30’ Radical treatment of brain metastases:


prof yamasoba curriculum vitae2017 53%

Bilateral isolated metastases of malignant melanoma to the cerebellopontine angle.


ER1086 52%

Hospital Universitario HM Sanchinarro, Madrid 17.35 -17.55 h Role of resection of the primary tumor in patients with GEP NETs and unresectable liver metastases / Papel de la resección del tumor primario en pacientes con TNE GEP y metástasis hepáticas irresecables Dr.


BTOG-2019-Programme-V7-Draft 50%

variation between primary tumour and nodal metastases Closing comments Close Sonja Kummer Nicholas Woznitza Ken O’Byrne Alexander Haragan Thursday 24th January 2019 13:00 – 14:00 Lunch, Exhibition and Posters Ground Floor Conference Foyer 13:10 - 13:50 Sponsored Satellite Symposia 13:10 Satellite symposium sponsored by Pfizer Pembroke/Herbert 14:00 – 15:30 Session 4:


Kasi - Vittal Poster - Final 46%

Imaging evaluation revealed marked hepatomegaly with multiple hepatic metastases and pelvic lymphadenopathy.


JDIT-2014-1028-005 43%

pathology showed positive surgical margins, involvement of seminal vesicles, bilateral lymph node metastases, and a Gleason score of 9.


813607 JD October2017 (3) 37%

The RAMPART clinic (Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment) was set up in early 2016 for patients with painful bone metastases offering a one stop assessment and treatment appointment as well as palliative care consultant and nurse specialist assessment.


JDIT-2014-1110-007 36%

The approved radionuclide therapies by the FDA and the EMA include iodine-131 iodide for differentiated thyroid cancer, strontium-89 chloride (Metastron) for bone pain, samarium-153 lexidronam (Quadramet) for bone pain, yttrium-90 ibritumomab tiuxetan (Zevalin®) for NHL, iodine-131 tositumomab (Bexxar) for NHL, radium-223 dichloride (Xofigo) for bone metastases, Lu-177-DOTA-octreotate (Lutathera) for NE tumors.


JDIT-2015-0202-011 35%

NETs are well differentiated tumours but often present metastases at diagnosis and therefore conventional imaging techniques create results which are insufficient for early diagnosis and therapy monitoring.